Stockscreener 앱 받기
6.00
1.52%
0.09
시간 외 거래:
5.98
-0.02
-0.33%
전일 마감가:
$5.91
열려 있는:
$5.91
하루 거래량:
54,093
Relative Volume:
0.12
시가총액:
$21.91M
수익:
$11.68M
순이익/손실:
$-8.85M
주가수익비율:
-1.2371
EPS:
-4.85
순현금흐름:
$-14.61M
1주 성능:
+4.35%
1개월 성능:
+6.76%
6개월 성능:
+210.90%
1년 성능:
+209.20%
1일 변동 폭
$5.80
$6.08
1주일 범위
$5.65
$6.57
52주 변동 폭
$1.55
$8.4399
Pulmatrix Inc Stock (PULM) Company Profile
명칭
Pulmatrix Inc
전화
(888) 355-4440
주소
945 CONCORD STREET, FRAMINGHAM, MA
PULM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
6.00 | 21.91M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-02-09 | 개시 | H.C. Wainwright | Buy |
Pulmatrix Inc 주식(PULM)의 최신 뉴스
Pulmatrix secures director positions and ratifies accounting firm - Investing.com
StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM) - Defense World
Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com - Defense World
Cullgen Entering Public Market with Pulmatrix Merger - San Diego Business Journal
Pulmatrix Announces Third Quarter 2024 Financial Results and Pro - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve
Finansavisen - Finansavisen
Pulmatrix and Cullgen announce proposed merger - MSN
Stock Market News: Samfine Creation Holdings drops by 21.56% while Pulmatrix dropped by almost 15% during mid day trading - Business Upturn
Pulmatrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - AccessWire
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc.PULM - Marketscreener.com
Pulmatrix (STU:2PU) Dividends per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com
Pulmatrix Shares Hit 52-Week High After News of Merger Deal - MarketWatch
Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options - Endpoints News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, ENTO, PIK, PFC on Behalf of Shareholders - AccessWire
U.S. Stock market top gainers: AgEagle Aerial Systems surges by 151.55% while Gaxos.ai Inc gains 47.58% in ealry trading - Business Upturn
Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders - The Bakersfield Californian
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
PULM stock touches 52-week high at $2.8 amid market optimism - Investing.com India
PULM stock touches 52-week high at $2.8 amid market optimism By Investing.com - Investing.com South Africa
Pulmatrix and Cullgen to Merge - citybiz
U.S. Stock market gains: BTC Digital Ltd. gains 79.72%, Kaixin Holdings surges 57.91% during mid day trading - Business Upturn
Pulmatrix Shares Surge on Merger with Cullgen - MarketWatch
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders - Business Wire
Pulmatrix To Merge With Cullgen - Contract Pharma
Cullgen and Pulmatrix set for merger, eye clinical trials By Investing.com - Investing.com South Africa
Pulmatrix and Cullgen Announce Strategic Merger Agreement - TipRanks
Cullgen and Pulmatrix set for merger, eye clinical trials - Investing.com
Cullgen to Absorb Pulmatrix, Join Nasdaq - MarketWatch
Pulmatrix announces merger agreement with Cullgen - TipRanks
Pulmatrix and Cullgen Announce Proposed Merger - PR Newswire
Pulmatrix Third Quarter 2024 Earnings: US$0.71 loss per share (vs US$1.03 loss in 3Q 2023) - Yahoo Finance
Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - citybiz
Pulmatrix Inc. (PULM) Quarterly 10-Q Report - Quartzy
Pulmatrix Q3 Revenue Falls 78%, But Cash Runway Extended to 2026 Despite Challenges - StockTitan
Head-To-Head Contrast: Sage Therapeutics (NASDAQ:SAGE) and Pulmatrix (NASDAQ:PULM) - Defense World
Pulmatrix presents data on inhaled drug delivery platform - Reuters
Pulmatrix sets date for 2024 annual stockholders meeting By Investing.com - Investing.com South Africa
Pulmatrix sets date for 2024 annual stockholders meeting - Investing.com India
Reviewing Pulmatrix (NASDAQ:PULM) & Emergent BioSolutions (NYSE:EBS) - Defense World
Pulmatrix, Inc. (NASDAQ:PULM) Short Interest Update - Defense World
Pulmatrix (NASDAQ:PULM) Now Covered by Analysts at StockNews.com - Defense World
Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.com - Defense World
Pulmatrix (NASDAQ:PULM) Shares Pass Above Fifty Day Moving Average of $2.10 - Defense World
Pulmatrix (NASDAQ:PULM) Stock Price Crosses Above Fifty Day Moving Average of $2.08 - Defense World
Pulmatrix Second Quarter 2024 Earnings: US$1.59 loss per share (vs US$1.05 loss in 2Q 2023) - Yahoo Finance
Pulmatrix (NASDAQ:PULM) Shares Pass Above 50-Day Moving Average of $2.06 - Defense World
PULM stock touches 52-week high at $2.75 amid market fluctuations - Investing.com
Pulmatrix Inc (PULM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):